Published in Am J Epidemiol on July 02, 2012
Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am J Epidemiol (2014) 1.50
Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease. Clin Rheumatol (2015) 1.40
Hyperuricemia causes pancreatic β-cell death and dysfunction through NF-κB signaling pathway. PLoS One (2013) 0.95
Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM (2013) 0.90
Risk of incident diabetes in patients with gout: a cohort study. Arthritis Rheumatol (2015) 0.89
Global metabolomic profiling targeting childhood obesity in the Hispanic population. Am J Clin Nutr (2015) 0.88
Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus. Diabetes Obes Metab (2015) 0.87
Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med (2015) 0.87
Serum uric acid levels and the risk of impaired fasting glucose: a prospective study in adults of north China. PLoS One (2013) 0.83
Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am (2014) 0.81
Predictive value of serum uric acid on left atrial spontaneous echo contrast in non-valvular atrial fibrillation patients. J Geriatr Cardiol (2015) 0.80
Asymptomatic hyperuricemia: is it time to intervene? Clin Rheumatol (2017) 0.79
Risk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort study. BMC Musculoskelet Disord (2013) 0.79
Serum uric acid and disorders of glucose metabolism: the role of glycosuria. Braz J Med Biol Res (2014) 0.77
[The role of uric acid in the insulin resistance in children and adolescents with obesity]. Rev Paul Pediatr (2015) 0.77
Genetic analysis of the ELOVL6 gene polymorphism associated with type 2 diabetes mellitus. Braz J Med Biol Res (2013) 0.77
Serum γ-glutamyltransferase and uric acid levels are associated with impaired fasting glucose in adults from Inner Mongolia, China. BMC Public Health (2013) 0.77
Luteolin prevents uric acid-induced pancreatic β-cell dysfunction. J Biomed Res (2014) 0.76
A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical Trial. Perm J (2016) 0.75
The effect of initiating pharmacologic insulin on serum uric acid levels in patients with diabetes: a matched cohort analysis. Semin Arthritis Rheum (2014) 0.75
Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study. Sci Rep (2016) 0.75
Higher blood hematocrit predicts hyperuricemia: a prospective study of 62,897 person-years of follow-up. Sci Rep (2015) 0.75
Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J Adv Res (2016) 0.75
Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med (2003) 7.25
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med (2010) 6.45
Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum (2011) 6.36
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med (2012) 2.12
A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science (2004) 1.95
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol (2011) 1.80
Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol (2003) 1.73
Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol (2004) 1.39
Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci (2011) 1.35
Malignancy in the setting of the anti-synthetase syndrome. J Clin Rheumatol (2008) 1.28
A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol (2007) 1.13
Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol (2011) 1.10
Hyperuricemia and the risk for subclinical coronary atherosclerosis--data from a prospective observational cohort study. Arthritis Res Ther (2011) 1.09
Clinical presentation and evaluation of dermatomyositis. Indian J Dermatol (2012) 1.08
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum (2013) 1.04
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken) (2014) 1.03
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis (2012) 1.00
Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol (2008) 0.99
Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest (2014) 0.96
Chronic kidney disease in gout in a managed care setting. BMC Nephrol (2011) 0.93
Patient-reported depression severity measured by the PHQ-9 and impact on work productivity: results from a survey of full-time employees in the United States. J Occup Environ Med (2013) 0.93
Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep (2013) 0.91
Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congest Heart Fail (2011) 0.89
Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry. Chest (2013) 0.88
Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res (Hoboken) (2015) 0.87
Congenital anomalies of kidney and urinary tract. Semin Nephrol (2010) 0.86
Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients. J Manag Care Pharm (2008) 0.86
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis. Clin Rheumatol (2013) 0.85
Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings. Curr Med Res Opin (2011) 0.84
Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. Arthritis Res Ther (2012) 0.83
Localized cutaneous fibrosing disorders. Rheum Dis Clin North Am (2013) 0.83
A novel PCLN-1 gene mutation in familial hypomagnesemia with hypercalciuria and atypical phenotype. Pediatr Nephrol (2006) 0.82
GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care setting. Dig Dis Sci (2009) 0.82
An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis. J Rheumatol (2011) 0.81
Calcinosis: pathophysiology and management. Curr Opin Rheumatol (2015) 0.81
Pathogenesis of dermatomyositis: role of cytokines and interferon. Curr Rheumatol Rep (2011) 0.80
Health care expenditures in ulcerative colitis: the perspective of a self-insured employer. J Occup Environ Med (2008) 0.80
Development and psychometric evaluation of 2 age-stratified versions of the Pediatric GERD Symptom and Quality of Life Questionnaire. J Pediatr Gastroenterol Nutr (2011) 0.79
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey. Arthritis Res Ther (2013) 0.79
Digital ischemic loss in systemic sclerosis. Int J Rheumatol (2010) 0.78
The molecular basis of blood pressure variation. Pediatr Nephrol (2012) 0.78
Association between severity of depression and self-perceived cognitive difficulties among full-time employees. Prim Care Companion CNS Disord (2013) 0.78
Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina. Thromb J (2005) 0.77
Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.77
Digital Sympathectomy in Patients With Scleroderma: An Overview of the Practice and Referral Patterns and Perceptions of Rheumatologists. Ann Plast Surg (2015) 0.77
A 39-year-old woman with lupus, myositis, and a recalcitrant vasculopathy. Arthritis Care Res (Hoboken) (2010) 0.77
Tyrosine kinases in inflammatory dermatologic disease. J Am Acad Dermatol (2010) 0.76
Management of the hand in systemic sclerosis. J Hand Surg Am (2013) 0.76
A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US. Curr Med Res Opin (2009) 0.75
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis. Int J Rheumatol (2011) 0.75
Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US. Curr Med Res Opin (2008) 0.75
Molecular profiling to diagnose a case of atypical dermatomyositis. J Invest Dermatol (2013) 0.75
Colonic ulceration as an unusual manifestation of vasculopathy in systemic sclerosis. Rheumatology (Oxford) (2010) 0.75
Coronary artery disease in patients with systemic lupus erythematosus. Nat Clin Pract Rheumatol (2005) 0.75
Radiologists' burden of inefficiency using conventional imaging workstations. J Am Coll Radiol (2013) 0.75